Search
Marker Therapeutics Inc
MRKRAdd to Watchlist
1.330USD
-0.020-1.48%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
22.21MMarket Cap
LossP/E TTM
Marker Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Marker Therapeutics Inc is 8.40, ranking 137 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.38, which is -90.88% below the recent high of -0.22 and -259.69% above the recent low of -8.56.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
